BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corchado-Cobos R, García-Sancha N, González-Sarmiento R, Pérez-Losada J, Cañueto J. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy. Int J Mol Sci 2020;21:E2956. [PMID: 32331425 DOI: 10.3390/ijms21082956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 García-Sancha N, Corchado-Cobos R, Bellido-Hernández L, Román-Curto C, Cardeñoso-Álvarez E, Pérez-Losada J, Orfao A, Cañueto J. Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2021;13:5134. [PMID: 34680282 DOI: 10.3390/cancers13205134] [Reference Citation Analysis]
2 Tanaka Y, Murata M, Oda Y, Furue M, Ito T. Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target? Biomedicines 2021;9:355. [PMID: 33808400 DOI: 10.3390/biomedicines9040355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Bennardo L, Bennardo F, Giudice A, Passante M, Dastoli S, Morrone P, Provenzano E, Patruno C, Nisticò SP. Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far? Curr Oncol 2021;28:2317-25. [PMID: 34201867 DOI: 10.3390/curroncol28040213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol 2021. [PMID: 34185311 DOI: 10.1111/bjd.20604] [Reference Citation Analysis]
5 de Jong E, Lammerts MUPA, Genders RE, Bouwes Bavinck JN. Update of advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 2022;36 Suppl 1:6-10. [PMID: 34855246 DOI: 10.1111/jdv.17728] [Reference Citation Analysis]
6 Liu T, Jiang F, Yu LY, Wu YY. Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation. Bioengineered 2022;13:6359-70. [PMID: 35212616 DOI: 10.1080/21655979.2022.2031419] [Reference Citation Analysis]
7 Zhang W, Yang X, Lv J, An S. Research on Correlations of miR-196a Expression with Progression and Prognosis of Cutaneous Squamous Cell Carcinoma. Clin Cosmet Investig Dermatol 2022;15:97-105. [PMID: 35082509 DOI: 10.2147/CCID.S323414] [Reference Citation Analysis]
8 Russo I, Fagotto L, Colombo A, Sartor E, Luisetto R, Alaibac M. Near-infrared photoimmunotherapy for the treatment of skin disorders. Expert Opin Biol Ther 2021;:1-9. [PMID: 34860146 DOI: 10.1080/14712598.2022.2012147] [Reference Citation Analysis]
9 Newman JG, Hall MA, Kurley SJ, Cook RW, Farberg AS, Geiger JL, Koyfman SA. Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review. Head Neck 2021;43:2822-43. [PMID: 34096664 DOI: 10.1002/hed.26767] [Reference Citation Analysis]
10 Hedberg ML, Berry CT, Moshiri AS, Xiang Y, Yeh CJ, Attilasoy C, Capell BC, Seykora JT. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2022;23:3478. [PMID: 35408839 DOI: 10.3390/ijms23073478] [Reference Citation Analysis]
11 Genenger B, Perry JR, Ashford B, Ranson M. A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review). Discov Oncol 2022;13:42. [PMID: 35666359 DOI: 10.1007/s12672-022-00510-4] [Reference Citation Analysis]
12 Cortés H, Reyes-Hernández OD, Alcalá-Alcalá S, Bernal-Chávez SA, Caballero-Florán IH, González-Torres M, Sharifi-Rad J, González-Del Carmen M, Figueroa-González G, Leyva-Gómez G. Repurposing of Drug Candidates for Treatment of Skin Cancer. Front Oncol 2020;10:605714. [PMID: 33489912 DOI: 10.3389/fonc.2020.605714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Temelie-olinici D, Bărgăoanu P, Foia I, Onofrei P, Dimitriu CD, Botez A, Stoica L, Grecu V, Cotrutz E. Ultrastructural Features of Keratoacanthoma—Clinical Implications. Applied Sciences 2022;12:5120. [DOI: 10.3390/app12105120] [Reference Citation Analysis]
14 McMullen CP, Ow TJ. The Role of Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma. Otolaryngol Clin North Am 2021;54:343-55. [PMID: 33583597 DOI: 10.1016/j.otc.2020.11.007] [Reference Citation Analysis]
15 Starkings R, Shilling V, Fallowfield L. An online review of informational sources for advanced or high-risk cutaneous squamous cell carcinoma. Support Care Cancer 2021;29:4199-207. [PMID: 33558963 DOI: 10.1007/s00520-021-06034-x] [Reference Citation Analysis]
16 Kumbhar P, Kole K, Yadav T, Bhavar A, Waghmare P, Bhokare R, Manjappa A, Jha NK, Chellappan DK, Shinde S, Singh SK, Dua K, Salawi A, Disouza J, Patravale V. Drug repurposing: An emerging strategy in alleviating skin cancer. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175031] [Reference Citation Analysis]
17 Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G, Donati M, Ricci F, Coco V, Ricci F, Candi E, Abeni D, Dellambra E. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:171. [PMID: 33572373 DOI: 10.3390/biomedicines9020171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
18 Minokawa Y, Sawada Y, Nakamura M. The Influences of Omega-3 Polyunsaturated Fatty Acids on the Development of Skin Cancers. Diagnostics (Basel) 2021;11:2149. [PMID: 34829495 DOI: 10.3390/diagnostics11112149] [Reference Citation Analysis]
19 Sawada Y, Nakamura M. Daily Lifestyle and Cutaneous Malignancies. Int J Mol Sci 2021;22:5227. [PMID: 34069297 DOI: 10.3390/ijms22105227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Bai X, Shan F, Qu N, Huang H, Handley M, Griffin N, Zhang S, Cao X. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma. Int Immunopharmacol 2021;99:107996. [PMID: 34311187 DOI: 10.1016/j.intimp.2021.107996] [Reference Citation Analysis]
21 Villani A, Ocampo-Garza SS, Potestio L, Fabbrocini G, Ocampo-Candiani J, Ocampo-Garza J, Scalvenzi M. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. Expert Opin Drug Saf 2021;:1-9. [PMID: 34644510 DOI: 10.1080/14740338.2022.1993819] [Reference Citation Analysis]
22 Zhang Z, Guo H, Yang W, Li J. Exosomal Circular RNA RNA-seq Profiling and the Carcinogenic Role of Exosomal circ-CYP24A1 in Cutaneous Squamous Cell Carcinoma. Front Med (Lausanne) 2021;8:675842. [PMID: 34109199 DOI: 10.3389/fmed.2021.675842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ashraf S, Alsharedi M. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report. Stem Cell Investig 2021;8:19. [PMID: 34631872 DOI: 10.21037/sci-2020-071] [Reference Citation Analysis]
24 Perry J, Ashford B, Thind AS, Gauthier ME, Minaei E, Major G, Iyer NG, Gupta R, Clark J, Ranson M. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities. Int J Mol Sci 2020;21:E9536. [PMID: 33333825 DOI: 10.3390/ijms21249536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M. The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies. Int J Mol Sci 2020;21:E9732. [PMID: 33419290 DOI: 10.3390/ijms21249732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]